VWA5B2 Activators
These VWA5B2 Activators are a group of compounds that have garnered significant attention within the field of molecular biology and biochemistry due to their unique ability to modulate the activity of the VWA5B2 protein. VWA5B2, short for Von Willebrand factor A domain-containing protein 5B2, is a protein domain commonly found in various organisms, including humans. It plays a crucial role in various cellular processes, particularly those related to cell adhesion and signaling. VWA5B2 Activators are a class of chemicals specifically designed to interact with and enhance the functional activity of this protein domain.
These activators typically function by binding to the VWA5B2 domain, inducing conformational changes that result in increased affinity for its natural ligands or partners. This enhanced binding capability can lead to a cascade of downstream effects within the cell, influencing processes such as cell adhesion, cell migration, and intracellular signaling. The study of VWA5B2 activators is essential for understanding the intricate molecular mechanisms underlying these cellular processes and their significance in various physiological contexts. Researchers are particularly interested in elucidating the specific structural features of these activators and how they interact with the VWA5B2 domain at the molecular level. Additionally, the identification of potential endogenous regulators of VWA5B2 activity is an ongoing area of investigation, as it may provide insights into the physiological relevance of this protein domain and its role in health and disease. In summary, VWA5B2 activators represent a class of chemicals that hold great promise for advancing our knowledge of cellular biology and the molecular mechanisms governing cell adhesion and signaling.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate proteins including VWA5B2, enhancing its activity related to cellular adhesion processes. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. PKA activation can lead to the phosphorylation of VWA5B2, thus potentially enhancing its functional role in cells. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, indirectly enhancing calcium-dependent pathways that VWA5B2 may be involved in, promoting its activity in cellular processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could phosphorylate VWA5B2 or modulate its interactions with other proteins, thereby possibly enhancing its function within the cell. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP levels, indirectly leading to PKA activation. Through this mechanism, VWA5B2 may be phosphorylated and activated, enhancing its cellular functions. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins. This could indirectly enhance the activity of VWA5B2 by maintaining its phosphorylated state. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to modulate kinase activity. By inhibiting certain kinases, it could potentially enhance VWA5B2 activity by reducing competitive signaling or by shifting the balance of phosphorylation in favor of VWA5B2's role in the cellular environment. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor which may lead to the selective activation of VWA5B2 by reducing the inhibitory phosphorylation exerted by certain kinases on proteins that interact with or regulate VWA5B2. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels. Elevated cAMP may enhance VWA5B2 activity through PKA activation, which may phosphorylate VWA5B2 or modulate its functional interactions. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase 5 (PDE5), resulting in increased cAMP and cGMP levels. This dual increase can lead to the activation of PKA and PKG, potentially promoting the phosphorylation and activation of VWA5B2 in cellular signaling pathways. | ||||||